Intervention not reported
Adverse events · preschool children (aged 0 to 6 years) with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Pregnancy (12 months) · women aged ≤ 25 years with desire for contraception
1 finding from 1 review
no estimate extracted
193 participants
Very low
Intervention not reported
Pregnancy (6 months) · women aged ≤ 25 years with desire for contraception
The intervention showed no clear difference in pregnancy (6 months) (moderate certainty).
1 finding from 1 review
OR 1 [0.05, 18.57]
20 participants
Moderate
Intervention not reported
Continuation (12 months) · women aged ≤ 25 years with desire for contraception
It is very uncertain whether the intervention changes continuation (12 months) (very low certainty).
1 finding from 1 review
OR 1.48 [0.76, 2.89]
193 participants
Very low
Intervention not reported
Continuation (1 month; 6 months) · women aged ≤ 25 years with desire for contraception
The intervention showed no clear difference in continuation (1 month; 6 months) (moderate certainty).
1 finding from 1 review
OR 2.44 [0.19, 31.53]
23 participants
Moderate
Intervention not reported
Continuation (cycles 1 to 3; cycles 4 to 6) · women aged ≤ 25 years with desire for contraception
The intervention showed no clear difference in continuation (cycles 1 to 3; cycles 4 to 6) (moderate certainty).
1 finding from 1 review
OR 1.09 [0.49, 2.42]
130 participants
Moderate
Intervention not reported
Continuation (6 months) · women aged ≤ 25 years with desire for contraception
The intervention showed no clear difference in continuation (6 months) (moderate certainty).
1 finding from 1 review
OR 0.38 [0.05, 2.77]
20 participants
Moderate
Intervention not reported
Discontinuation: other personal reasons (12 months) · women aged ≤ 25 years with desire for contraception
It is very uncertain whether the intervention changes discontinuation: other personal reasons (12 months) (very low certainty).
1 finding from 1 review
OR 0.27 [0.09, 0.85]
193 participants
Very low
Intervention not reported
Discontinuation: pain, hormonal, bleeding, spotting, other medical, or planning pregnancy (12 months) · women aged ≤ 25 years with desire for contraception
1 finding from 1 review
no estimate extracted
193 participants
Very low
Weight gain · Low‐ and middle‐income children aged 3 months to 5 years
1 finding from 1 review
Weight‐for‐length/height z‐score at the end of the intervention Weight scale, measurement boards and child growth reference · Children aged 3 months to 5 years
1 finding from 1 review
Mental development index (MDI) at 18 months · Children aged 3 months to 5 years
1 finding from 1 review
Psychomotor development · Children aged 3 months to 5 years
1 finding from 1 review
Height gain (cm) · Low‐ and middle‐income children aged 3 months to 5 years
1 finding from 1 review
Weight‐for‐length/height z‐score at the end of the intervention Weight scale, measurement boards and child growth reference · Low‐ and middle‐income children aged 3 months to 5 years
1 finding from 1 review
Weight gain · Children aged 3 months to 5 years
1 finding from 1 review
Height gain (cm) · Children aged 3 months to 5 years
1 finding from 1 review
Intervention not reported
Incidence of pulmonary tuberculosis in children with HIV infection ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of pulmonary tuberculosis in children with HIV infection ‐… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mean FEV1 % predicted ‐ azithromycin prophylaxis only · children with cystic fibrosis aged 12 years and under
1 finding from 1 review
Intervention not reported
Mean FEV1 % predicted ‐ ciprofloxacin prophylaxis only · children with cystic fibrosis aged 12 years and under
1 finding from 1 review